Tango Therapeutics Inc (TNGX)

Tango Therapeutics Inc (TNGX) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $4.5B; returns 1 day -16.4%, 1 week +5.9%, 1 year +210.0%.

Tango Therapeutics Inc (TNGX) is a clinical-stage biotechnology company primarily focused on discovering and developing precision cancer medicines. The company's core strategy revolves around leveraging the genetic principle of synthetic lethality through its proprietary CRISPR-based functional genomics screening platform.

Groups TNGX belongs to

• Biotechnology
• Clinical Stage Biotech
• Oncology
• Cancer Therapeutics
• Precision Medicine
• Life Sciences
• Clinical Stage
• Biopharmaceutical
• Drug Discovery

TNGX financial model: income statement, cash flow and balance sheet